KURAMOTO Kenta 倉元謙太

Researcher Number	80768755
Other IDs	https://orcid.org/0000-0002-7923-578X
Affiliation (based on the past Project Information) *help	2016 – 2017: 山形大学, 医学部, 助教
Review Section/Research Field	Principal Investigator Tumor biology
Keywords	Principal Investigator グルタミン代謝 / がん幹細胞

Elucidation of the role of glutamine as a metabolic signaling molecule in cancer stem cells.Principal Investigator
- Principal Investigator
  
  KURAMOTO Kenta
- Project Period (FY)
  2016 – 2017
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Tumor biology
- Research Institution
  Yamagata University

All 2017 2016

All Journal Article

[Journal Article] Olanzapine, an Atypical Antipsychotic, Inhibits Survivin Expression and Sensitizes Cancer Cells to Chemotherapeutic Agents.2017
- Author(s)
  Sanomachi Tomomi、Suzuki Shuhei、Kuramoto Kenta、Takeda Hiroyuki、Sakaki Hirotsugu、Togashi Keita、Seino Shizuka、Yoshioka Takashi、Okada Masashi、Kitanaka Chifumi
- Journal Title
  
  Anticancer Res.
  
  Volume: 37 Pages: 6177-6188
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K18410
[Journal Article] Repositioning CEP-1347, a chemical agent originally developed for the treatment of Parkinson's disease, as an anti-cancer stem cell drug.2017
- Author(s)
  Okada M, Takeda H, Sakaki H, Kuramoto K, Suzuki S, Sanomachi T, Togashi K, Seino S, Kitanaka C.
- Journal Title
  
  Oncotarget.
  
  Volume: 8 Issue: 55 Pages: 94872-94882
- DOI
  10.18632/oncotarget.22033
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K07160, KAKENHI-PROJECT-16K15640, KAKENHI-PROJECT-16K18410, KAKENHI-PROJECT-15H04946
[Journal Article] Antitumor activity of gemcitabine against high-grade meningioma in vitro and in vivo.2017
- Author(s)
  Takeda H, Okada M, Kuramoto K, Suzuki S, Sakaki H, Sanomachi T, Seino S, Yoshioka T, Hirano H, Arita K, Kitanaka C.
- Journal Title
  
  Oncotarget.
  
  Volume: 8 Issue: 53 Pages: 90996-91008
- DOI
  10.18632/oncotarget.18827
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K07160, KAKENHI-PROJECT-15K10338, KAKENHI-PROJECT-16K18410
[Journal Article] Licochalcone A specifically induces cell death in glioma stem cells via mitochondrial dysfunction.2017
- Author(s)
  Kuramoto K, Suzuki S, Sakaki H, Takeda H, Sanomachi T, Seino S, Narita Y, Kayama T, Kitanaka C, Okada M.
- Journal Title
  
  FEBS Open Bio.
  
  Volume: 7 Issue: 6 Pages: 835-844
- DOI
  10.1002/2211-5463.12226
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K07160, KAKENHI-PROJECT-16K15640, KAKENHI-PROJECT-16K18410, KAKENHI-PROJECT-15H04946
[Journal Article] Time-staggered inhibition of JNK effectively sensitizes chemoresistant ovarian cancer cells to cisplatin and paclitaxel2016
- Author(s)
  Seino M, Okada M, Sakaki H, Takeda H, Watarai H, Suzuki S, Seino S, Kuramoto K, Ohta T, Nagase S, Kurachi H, Kitanaka C
- Journal Title
  
  Oncology Reports
  
  Volume: 35 Issue: 1 Pages: 593-601
- DOI
  10.3892/or.2015.4377
- Peer Reviewed / Acknowledgement Compliant / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K20125, KAKENHI-PROJECT-26830065, KAKENHI-PROJECT-15K18437, KAKENHI-PROJECT-16K18410
[Journal Article] Aripiprazole, an Antipsychotic and Partial Dopamine Agonist, Inhibits Cancer Stem Cells and Reverses Chemoresistance.2016
- Author(s)
  Suzuki S, Okada M, Kuramoto K, Takeda H, Sakaki H, Watarai H, Sanomachi T, Seino S, Yoshioka T, Kitanaka C.
- Journal Title
  
  Anticancer Res.
  
  Volume: 10 Issue: 10 Pages: 5153-5161
- DOI
  10.21873/anticanres.11085
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-16K07160, KAKENHI-PROJECT-16K18410
[Journal Article] Autophagy activation by novel inducers prevents BECN2-mediated drug tolerance to cannabinoids.2016
- Author(s)
  K. Kuramoto, N. Wang, Y. Fan, W. Zhang, FJ. Schonen, KJ. Frankowski, J. Marugan, Y. Zhou, S. Huang, C. He.
- Journal Title
  
  Autophagy
  
  Volume: 12 Issue: 9 Pages: 1460-1471
- DOI
  10.1080/15548627.2016.1187367
- Peer Reviewed / Acknowledgement Compliant / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K18410
[Journal Article] Rho-Associated Protein Kinase (ROCK) Inhibitors Inhibit Survivin Expression and Sensitize Pancreatic Cancer Stem Cells to Gemcitabine.2016
- Author(s)
  Takeda H, Okada M, Suzuki S, Kuramoto K, Sakaki H, Watarai H, Sanomachi T, Seino S, Yoshioka T, Kitanaka C.
- Journal Title
  
  Anticancer Res.
  
  Volume: 12 Issue: 12 Pages: 6311-6318
- DOI
  10.21873/anticanres.11227
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-16K07160, KAKENHI-PROJECT-16K18410
[Journal Article] The novel JNK inhibitor AS602801 inhibits cancer stem cells in vitro and in vivo.2016
- Author(s)
  Okada M, Kuramoto K, Takeda H, Watarai H, Sakaki H, Seino S, Seino M, Suzuki S, Kitanaka C.
- Journal Title
  
  Oncotarget
  
  Volume: 19 Issue: 19 Pages: 27021-27032
- DOI
  10.18632/oncotarget.8395
- Peer Reviewed / Acknowledgement Compliant / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26830065, KAKENHI-PROJECT-15H04946, KAKENHI-PROJECT-15K18437, KAKENHI-PROJECT-15K20125, KAKENHI-PROJECT-16K07160, KAKENHI-PROJECT-16K18410
[Journal Article] Heart lipid droplets and lipid droplet-binding proteins: Biochemistry, physiology, and pathology.2016
- Author(s)
  Osumi, T., Kuramoto, K.
- Journal Title
  
  Experimental Cell Research
  
  Volume: 340 Issue: 2 Pages: 198-204
- DOI
  10.1016/j.yexcr.2015.10.031
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-25440053, KAKENHI-PROJECT-16K18410

1. OKADA Masashi

# of Collaborated Projects: 0 results

# of Collaborated Products: 6 results
2. 清野学

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
3. 大隅隆

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

KURAMOTO Kenta 倉元 謙太

Research Projects

Research Products

Co-Researchers

Elucidation of the role of glutamine as a metabolic signaling molecule in cancer stem cells.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Olanzapine, an Atypical Antipsychotic, Inhibits Survivin Expression and Sensitizes Cancer Cells to Chemotherapeutic Agents.2017

Author(s)

Journal Title

Data Source

[Journal Article] Repositioning CEP-1347, a chemical agent originally developed for the treatment of Parkinson's disease, as an anti-cancer stem cell drug.2017

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Antitumor activity of gemcitabine against high-grade meningioma in vitro and in vivo.2017

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Licochalcone A specifically induces cell death in glioma stem cells via mitochondrial dysfunction.2017

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Time-staggered inhibition of JNK effectively sensitizes chemoresistant ovarian cancer cells to cisplatin and paclitaxel2016

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Aripiprazole, an Antipsychotic and Partial Dopamine Agonist, Inhibits Cancer Stem Cells and Reverses Chemoresistance.2016

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Autophagy activation by novel inducers prevents BECN2-mediated drug tolerance to cannabinoids.2016

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Rho-Associated Protein Kinase (ROCK) Inhibitors Inhibit Survivin Expression and Sensitize Pancreatic Cancer Stem Cells to Gemcitabine.2016

Author(s)

Journal Title

DOI

Data Source

[Journal Article] The novel JNK inhibitor AS602801 inhibits cancer stem cells in vitro and in vivo.2016

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Heart lipid droplets and lipid droplet-binding proteins: Biochemistry, physiology, and pathology.2016

Author(s)

Journal Title

DOI

Data Source

KURAMOTO Kenta 倉元謙太